The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism
Open accessAbstract
Background: Congenital hyperinsulinism (CHI) is a clinically heterogeneous condition. Mutations in eight genes (ABCC8,KCNJ11,GLUD1,GCK,HADH,SLC16A1,HNF4A and HNF1A) are known to cause CHI. Aim: To characterise the clinical and molecular aspects of a large cohort of patients with CHI. Methodology: Three hundred patients were recruited and clinical information was collected before genotyping.ABCC8 and KCNJ11 genes were analysed in all patients. Mutations in GLUD1,HADH,GCK and HNF4A genes were sought in patients with diazoxide-responsive CHI with hyperammonaemia (GLUD1), raised 3-hydroxybutyrylcarnitine and/or consanguinity (HADH), positive family history (GCK) or when CHI was diagnosed within the first week of life (HNF4A). Results: Mutations were identified in 136/300 patients (45.3%). Mutations in ABCC8/KCNJ11 were the commonest genetic cause identified (n=109, 36.3%). Among diazoxide-unresponsive patients (n=105), mutations in ABCC8/KCNJ11 were identified in 92 (87.6%) patients, of whom 63 patients had recessively inherited mutations while four patients had dominantly inherited mutations. A paternal mutation in the ABCC8/KCNJ11 genes was identified in 23 diazoxide-unresponsive patients, of whom six had diffuse disease. Among the diazoxide-responsive patients (n=183), mutations were identified in 41 patients (22.4%). These include mutations in ABCC8/KCNJ11(n=15),HNF4A(n=7),GLUD1(n=16) and HADH(n=3). Conclusions: A genetic diagnosis was made for 45.3% of patients in this large series. Mutations in the ABCC8 gene were the commonest identifiable cause. The vast majority of patients with diazoxide-responsive CHI (77.6%) had no identifiable mutations, suggesting other genetic and/or environmental mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A rare pathogenic variant in ABCC8 that causes congenital hyperinsulinism was incorrectly genotyped as homozygous in 43% (9/21) of individuals.”
From Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation (2021) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A rare pathogenic variant in ABCC8 that causes congenital hyperinsulinism [29] is incorrectly genotyped in 43% (9/21) of individuals.”
From Assessing the analytical validity of SNP-chips for detecting very rare pathogenic variants: implications for direct-to-consumer genetic testing (2019) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thomas, P. M., Cote, G. J., Wohllk, N., Haddad, B., Mathew, P. M., Rabl, W., Aguilar-Bryan, L., Gagel, R. F., & Bryan, J. (1995) · Science · doi:10.1126/science.7716548 · Cited by 806
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Aguilar‐Bryan, L., & Bryan, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0361 · Cited by 698
Adenosine Diphosphate as an Intracellular Regulator of Insulin Secretion
Nichols, C. G., Shyng, S., Nestorowicz, A., Gläser, B., Clement, J. P., González, G., Aguilar‐Bryan, L., Permutt, M. A., & Bryan, J. (1996) · Science · doi:10.1126/science.272.5269.1785 · Cited by 525
Thomas, P. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.11.1809 · Cited by 443
Pearson, E. R., Boj, S. F., Steele, A. M., Barrett, T. G., Stals, K. L., Hamilton-Shield, J. P., Ellard, S., Ferrer, J. P., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 436
Self-citationClayton, P. T., Eaton, S. D., Aynsley-Green, A., Edginton, M., Hussain, K., Krywawych, S., Datta, V., Malingré, H. E. M., Berger, R., & van den Berg, I. E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111294 · Cited by 311
Self-citationClinical features of 52 neonates with hyperinsulinism.
de Lonlay-Debeney, P., Poggi-Travert, F., Fournet, J., Sempoux, C., Vici, C., Brunelle, F., Touati, G., Rahier, J., Junien, C., Nihoul-Fékété, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401505 · Cited by 306
Practical management of hyperinsulinism in infancy
Aynsley-Green, A., Hussain, K., Hall, J., Saudubray, J., Nihoul‐Feketé, C., de Lonlay, P., Brunelle, F., Otonkoski, T., Thornton, P., & Lindley, K. J. (2000) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.82.2.f98 · Cited by 298
Self-citationVerkarre, V., Fournet, J., de Lonlay, P., Gross, M., Devillers, M., Rahier, J., Brunelle, F., Robert, J., Nihoul‐Feketé, C., Saudubray, J., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4495 · Cited by 289
Regulation of KATP Channel Activity by Diazoxide and MgADP
Shyng, S.-L., Ferrigni, T., & Nichols, C. G. (1997) · The Journal of General Physiology · doi:10.1085/jgp.110.6.643 · Cited by 282
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1
Huopio, H., Reimann, F. M., Ashfield, R., Komulainen, J., Lenko, H. L., Rahier, J., Vauhkonen, I., Kere, J., Laakso, M., Ashcroft, F. M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9804 · Cited by 277 · cited 1×
“The phenotype associated with these dominantly inherited mutations confirms the reported phenotype associated with dominant mutations in the NBD2 area (13, 43); however, dominant CHI mutations also occur outside the NBD2 (44).”
Otonkoski, T., Näntö‐Salonen, K., Seppänen, M., Veijola, R., Huopio, H., Hussain, K., Tapanainen, P. J., Eskola, O., Parkkola, R. K., Ekström, K., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1128 · Cited by 268 · cited 1×
“Using 18F-L -DOPA-PET/CT, it is now possible to pre-operatively localise the focal lesion (31).”
Self-citationNestorowicz, A. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.11.1813 · Cited by 245
Otonkoski, T., Jiao, H., Kaminen‐Ahola, N., Tapia‐Páez, I., Ullah, M. S., Parton, L. E., Schuit, F. C., Quintens, R., Sipilä, I., Mayatepek, E., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520960 · Cited by 235
Diagnosis and Localization of Focal Congenital Hyperinsulinism by 18F-Fluorodopa PET Scan
Hardy, O. T., Hernandez‐Pampaloni, M., Saffer, J. R., Suchi, M., Ruchelli, E. D., Zhuang, H., Ganguly, A. A., Freifelder, R. H., Adzick, N. S., Alavi, A. A., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.08.028 · Cited by 231
Intracellular ADP activates K+ channels that are inhibited by ATP in an insulin‐secreting cell line
Dunne, M. J., & Petersen, O. H. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81532-0 · Cited by 229
Kane, C., Shepherd, R. M., Squires, P. E., Johnson, P., James, R. F. L., Milla, P. J., Aynsley-Green, A., Lindley, K. J., & Dunne, M. J. (1996) · Nature Medicine · doi:10.1038/nm1296-1344 · Cited by 227
Dunne, M. J., Kane, C., Shepherd, R. M., Sánchez, J. A., James, R. F. L., Johnson, P., Aynsley-Green, A., Lu, S., Clement, J. P., Lindley, K. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361005 · Cited by 217 · cited 1×
“2 subunits of the pancreatic b -cell ATP-sensitive K C (K ATP ) channel respectively, are the most common known cause of CHI (9, 10, 11, 12).”
Pinney, S. E., MacMullen, C., Becker, S. A., Lin, Y., Hanna, C. E., THORNTON, P. S., Ganguly, A. A., Shyng, S., & Stanley, C. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35414 · Cited by 204
Molven, A., Matre, G. E., Durán, M., Wanders, R. J. A., Rishaug, U., Njølstad, P. R., Jellum, E., & Sövik, O. (2004) · Diabetes · doi:10.2337/diabetes.53.1.221 · Cited by 202 · cited 1×
“Loss-of-function mutations in the HADH gene are associated with CHI and protein sensitivity but with normal serum ammonia levels (21, 22, 23, 24, 25).”
Severe Persistent Hyperinsulinemic Hypoglycemia due to a De Novo Glucokinase Mutation
Cuesta-Muñoz, A. L., Huopio, H., Otonkoski, T., Gómez‐Zumaquero, J. M., Näntö‐Salonen, K., Rahier, J., López-Enriquez, S., García-Gimeno, M. A., Sanz, P., Soriguer, F. C., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2164 · Cited by 197 · cited 1×
“Heterozygous activating GCK mutations cause CHI, which in most cases is medically responsive but in some cases surgery may be required (18, 19, 20).”
Li, C., Chen, P., Palladino, A., Narayan, S. B., Russell, L. K., Sayed, S. U., Xiong, G., Chen, J., Stokes, D., Butt, Y. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123638 · Cited by 179
Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes:HNF1AandHNF4A
Stanescu, D. E., Hughes, N., Kaplan, B., Stanley, C. A., & León, D. D. D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1356 · Cited by 173
Shyng, S., Ferrigni, T., Shepard, J. B., Nestorowicz, A., Gläser, B., Permutt, M. A., & Nichols, C. G. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1145 · Cited by 165
Cartier, E. A., Conti, L. R., Vandenberg, C. A., & Shyng, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051499698 · Cited by 164
Otonkoski, T., Ämmälä, C., Huopio, H., Cote, G. J., Chapman, J., Cosgrove, K. E., Ashfield, R., Huang, E. S., Komulainen, J., Ashcroft, F. M., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.2.408 · Cited by 155 · cited 1×
“Two ABCC8 mutations, c.3992-9G O A and p.F1388del, are associated with CHI in the Ashkenazi Jewish population (11) and the p.V187D mutation has been associated with the Finnish population (46).”
Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases
de Lonlay, P., Fournet, J., Touati, G., Groos, M.-S., Martin, D., Sevin, C., Delagne, V., Mayaud, C., Chigot, V., Sempoux, C. L., et al. (2001) · European Journal of Pediatrics · doi:10.1007/s004310100847 · Cited by 151
Kapoor, R. R., Locke, J. M., Colclough, K., Wales, J. K., CONN, J. J., Hattersley, A. T., Ellard, S., & Hussain, K. (2008) · Diabetes · doi:10.2337/db07-1657 · Cited by 151
Self-citationOtonkoski, T., Kaminen‐Ahola, N., Ustinov, J., Lapatto, R., Meißner, T., Mayatepek, E., Kere, J., & Sipilä, I. (2003) · Diabetes · doi:10.2337/diabetes.52.1.199 · Cited by 150 · cited 1×
“Mutations in the promoter region of SLC16A1 gene have been described in patients with exercise-induced HI (26, 27).”
Rahier, J., Guiot, Y., & Sempoux, C. L. (2000) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.82.2.f108 · Cited by 149
The genetic basis of congenital hyperinsulinism
James, C. T., Kapoor, R. R., Ismail, D., & Hussain, K. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064337 · Cited by 148 · cited 1×
“So far, mutations in eight different genes ( ABCC8 , KCNJ11 , GLUD1 , GCK , HADH , SLC16A1 , HNF4A and HNF1A ) that lead to dysregulated secretion of insulin have been described (7, 8).”
Self-citationDiazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations
Flanagan, S. E., Kapoor, R. R., Mali, G., Cody, D., Murphy, N., Schwahn, B., Siahanidou, T., Banerjee, I., Akçay, T., Rubio‐Cabezas, O., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0861 · Cited by 146 · cited 1×
“The phenotypic characteristics of these patients have been previously reported (37).”
Self-citationHsu, B. Y. L., Kelly, A. T., THORNTON, P. S., Greenberg, C. R., Dilling, L. A., & Stanley, C. A. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111818 · Cited by 141 · cited 1×
“However, some forms of CHI demonstrate protein and/or leucine sensitivity and symptoms are manifested or aggravated in the postprandial period following a protein-rich meal rather than a fast (5).”
InfluentialHyperinsulinaemic hypoglycaemia
Kapoor, R. R., Flanagan, S. E., James, C. T., Hamilton-Shield, J. P., Ellard, S., & Hussain, K. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.148171 · Cited by 141 · cited 1×
“Patients with a secondary cause of hyperinsulinaemic hypogly-caemia such as perinatal asphyxia, intra-uterine growth restriction, Rhesus isoimmunisation and syndromic forms such as Beckwith–Wiedemann syndrome were excluded from the study (33).”
Self-citationGenetic Heterogeneity in Familial Hyperinsulinism
Nestorowicz, A., Gläser, B., Wilson, B. A., Shyng, S., Nichols, C. G., Stanley, C. A., THORNTON, P. S., & Permutt, M. A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1119 · Cited by 122
Stanley, C. A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.10.013 · Cited by 119 · cited 1×
“Gain-of-function mutations in the GLUD1 gene, which encodes for the intra-mitochondrial enzyme glutamate dehydrogenase (GDH), form the molecular and biochemical basis of the hyperinsulinism and hyperammonaemia (HI/HA) syndrome and explain the link between leucine hypersensitivity and the HA (17).”
Bellanné‐Chantelot, C., Saint‐Martin, C., Ribeiro, M.-J., Vaury, C., Verkarre, V., Arnoux, J.-B., Valayannopoulos, V., Gobrecht, S., Sempoux, C. L., Rahier, J., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.075416 · Cited by 118 · cited 1×
“The mechanism of diffuse disease in patients with a heterozygous paternal ABCC8/KCNJ11 mutation is not understood, but similar observations have been documented in a previous study (45).”
Sayed, S. U., Langdon, D. R., Odili, S., Chen, P., Buettger, C. W., Schiffman, A. B., Suchi, M., Taub, R. A., Grimsby, J. S., Matschinsky, F. M., et al. (2009) · Diabetes · doi:10.2337/db08-1792 · Cited by 118
Gloyn, A. L., Siddiqui, J., & Ellard, S. (2006) · Human Mutation · doi:10.1002/humu.20292 · Cited by 111
Self-citationYan, F.-F., Lin, Y., MacMullen, C., Ganguly, A. A., Stanley, C. A., & Shyng, S. (2007) · Diabetes · doi:10.2337/db07-0150 · Cited by 110
Stanley, C. A., THORNTON, P. S., Ganguly, A. A., MacMullen, C., UNDERWOOD, P. C., Bhatia, P., Steinkrauss, L. J., Wanner, L. A., Kaye, R. D., Ruchelli, E. D., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030965 · Cited by 104
p57KIP2 Expression in Normal Islet Cells and in Hyperinsulinism of Infancy
Kassem, S., Ariel, I., THORNTON, P. S., Hussain, K., Smith, V. V., Lindley, K. J., Aynsley-Green, A., & Gläser, B. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2763 · Cited by 102
Self-citationKapoor, R. R., Flanagan, S. E., Fulton, P., Chakrapani, A., Chadefaux, B., Ben‐Omran, T., Banerjee, I., Hamilton-Shield, J. P., Ellard, S., & Hussain, K. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0615 · Cited by 99 · cited 1×
“The genotype– phenotype correlations of these patients have been reported (36).”
Self-citationHyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations
Kapoor, R. R., Flanagan, S. E., James, C. T., McKiernan, J., Thomas, A., Harmer, S. C., Hamilton-Shield, J. P., Tinker, A., Ellard, S., & Hussain, K. (2011) · Diabetologia · doi:10.1007/s00125-011-2207-4 · Cited by 98 · cited 3×
“…acting as i) the family member testing demonstrated that the mutation had arisen de novo , ii) a second mutation was not detected by sequencing or MLPA analysis and iii) a different mutation affecting the same residue has been reported previously in patients with dominantly inherited CHI (13, 34).”
Self-citationChristesen, H. T., Tribble, N. D., Molven, A., Siddiqui, J., Sandal, T., Brusgaard, K., Ellard, S., Njølstad, P. R., Alm, J., Jacobsen, B. B., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0203 · Cited by 90
Self-citationThe surgical management of congenital hyperinsulinemic hypoglycemia in infancy
Nihoul‐Feketé, C., de Lonlay, P., Jaubert, F., Rahier, J., Brunelle, F., & Saudubray, J. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2003.11.004 · Cited by 86
Banerjee, I., Skae, M. S., Flanagan, S. E., Rigby, L., Patel, L., Didi, M., Blair, J., Ehtisham, S., Ellard, S., Cosgrove, K. E., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1136 · Cited by 86
Self-citationTornovsky-Babeay, S., Crane, A., Cosgrove, K. E., Hussain, K., Lavie, J., Heyman, M., Nesher, Y., Kuchinski, N., Ben-Shushan, E., Shatz, O., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1233 · Cited by 86
Self-citationGläser, B., Ryan, F., Donath, M. Y., Landau, H., Stanley, C. A., Baker, L. W., Barton, D. E., & THORNTON, P. S. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1652 · Cited by 81
Kapoor, R. R., James, C. T., Flanagan, S. E., Ellard, S., Eaton, S. D., & Hussain, K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0423 · Cited by 80
Self-citationPermanent diabetes during the first year of life: multiple gene screening in 54 patients
the ISPED Early Diabetes Study Group, Russo, L., Iafusco, D., Brescianini, S., Nocerino, V., Bizzarri, C., Toni, S., Cerutti, F., Monciotti, C., Pesavento, R., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2094-8 · Cited by 73
Histopathology of Congenital Hyperinsulinism: Retrospective Study with Genotype Correlations
Suchi, M., MacMullen, C., THORNTON, P. S., Ganguly, A. A., Stanley, C. A., & Ruchelli, E. D. (2003) · Pediatric and Developmental Pathology · doi:10.1007/s10024-002-0026-9 · Cited by 72
Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism
Suchi, M., MacMullen, C., THORNTON, P. S., Adzick, N. S., Ganguly, A. A., Ruchelli, E. D., & Stanley, C. A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800497 · Cited by 71
Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene
Hussain, K., Clayton, P. T., Krywawych, S., Chatziandreou, I., Mills, P. B., Ginbey, D. W., Geboers, A. J. J. M., Berger, R., van den Berg, I. E. T., & Eaton, S. D. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.01.032 · Cited by 70 · cited 1×
“Loss-of-function mutations in the HADH gene are associated with CHI and protein sensitivity but with normal serum ammonia levels (21, 22, 23, 24, 25).”
Self-citationMacMullen, C., Zhou, Q., Snider, K. E., Tewson, P. H., Becker, S. A., Aziz, A. R., Ganguly, A. A., Shyng, S., & Stanley, C. A. (2011) · Diabetes · doi:10.2337/db10-1631 · Cited by 70
Tanizawa, Y., Matsuda, K., Matsuo, M., Ohta, Y., Ochi, N., Adachi, M., Koga, M., Mizuno, S., Kajita, M., Tanaka, Y., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.1.114 · Cited by 66
Transmembrane Topology of the Sulfonylurea Receptor SUR1
Conti, L. R., Radeke, C. M., Shyng, S., & Vandenberg, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106555200 · Cited by 64
Mutation spectra ofABCC8 gene in Spanish patients with hyperinsulinism of infancy (HI)
Marmiesse, A. F., Salas, A., Vega, A., Lorenzo, J. R. F., Barreiro, J., & Carracedo, Á. (2006) · Human Mutation · doi:10.1002/humu.9401 · Cited by 56
Factors Determining Patient Choice of Device for GH Therapy
Wickramasuriya, B. P. N., Casey, A., Akhtar, S., Zia, R., Ehtisham, S., Barrett, T. G., Shaw, N. J., & Kirk, J. M. W. (2005) · Hormone Research in Paediatrics · doi:10.1159/000090375 · Cited by 55
Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins.
Ueda, K., Matsuo, M., Tanabe, K., Morita, K., Kioka, N., & Amachi, T. (1999) · Biochimica et Biophysica Acta · doi:10.1016/s0005-2736(99)00157-1 · Cited by 54 · cited 1×
“These binding domains cooperate with each other in mediating the nucleotide regulation of the pore function (39).”
Flanagan, S. E., Kapoor, R. R., Banerjee, I., Hall, C., Smith, V. V., Hussain, K., & Ellard, S. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01476.x · Cited by 46
Self-citationMatsuo, M., Trapp, S., Tanizawa, Y., Kioka, N., Amachi, T., Oka, Y., Ashcroft, F. M., & Ueda, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006503200 · Cited by 43 · cited 1×
“…inactivating ABCC8 and KCNJ11 mutations involves multiple defects in channel biogenesis and turnover, in channel trafficking from the endoplasmic reticulum and Golgi apparatus to the plasma membrane and alterations in the sensitivity of the channel to both magnesium ATP and ADP (14, 15, 16).”
Yorifuji, T., Kawakita, R., Nagai, S., Sugimine, A., Doi, H., Nomura, A., Masue, M., Nishibori, H., Yoshizawa, A., Okamoto, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1281 · Cited by 43
Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism
Shimomura, K., Flanagan, S. E., Dashevsky, B. Z., Lethby, M., Zubcevic, L., Girard, C. A. J., Petz, O., Männikkö, R., Kapoor, R. R., Hussain, K., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900018 · Cited by 39 · cited 1×
“In one of these patients (patient 148), who has been reported previously, a giant focal lesion was observed (35).”
Self-citationDarendelıler, F., Fournet, J., Baş, F., Junien, C., Gross, M., Bundak, R., Saka, N., & Günöz, H. (2002) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2002.15.7.993 · Cited by 38
Familial Focal Congenital Hyperinsulinism
Ismail, D., Smith, V. V., de Lonlay, P., Ribeiro, M. J., Rahier, J., Blankenstein, O., Flanagan, S. E., Bellanné‐Chantelot, C., Verkarre, V., Aigrain, Y. Y., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1524 · Cited by 37
Self-citationPark, S. E., Flanagan, S. E., Hussain, K., Ellard, S., Shin, C. H., & Yang, S. W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0160 · Cited by 37
Self-citationGiurgea, I., Sempoux, C. L., Bellanné‐Chantelot, C., Ribeiro, M. J., Hubert, L., Boddaert, N., Saudubray, J., Robert, J., Brunelle, F., Rahier, J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0397 · Cited by 36
The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy
Sandal, T., Laborie, L., Brusgaard, K., Eide, S., Christesen, H. T., Søvik, O., Pr, N., & Molven, A. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01152.x · Cited by 33
The Heterogeneity of Focal Forms of Congenital Hyperinsulinism
Ismail, D., Kapoor, R. R., Smith, V. V., Ashworth, M. T., Blankenstein, O., Pierro, A., Flanagan, S. E., Ellard, S., & Hussain, K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1628 · Cited by 33
Self-citationKumaran, A., Kapoor, R. R., Flanagan, S. E., Ellard, S., & Hussain, K. (2010) · Hormone Research in Paediatrics · doi:10.1159/000284394 · Cited by 26
Self-citationComplex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies
Muzyamba, M. C., Farzaneh, T., Behe, P., Thomas, A., Christesen, H. T., Brusgaard, K., Hussain, K., & Tinker, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02847.x · Cited by 25
Self-citationÖçal, G., Flanagan, S. E., Hacıhamdioğlu, B., Berberoğlu, M., Şıklar, Z., Ellard, S., Erdeve, Ş. S., Okulu, E., Akın, İ. M., Atasay, B., et al. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.347 · Cited by 24
Self-citationGenotype-Phenotype Associations in Patients with Severe Hyperinsulinism of Infancy
Greer, R. M., Shah, J. H., Jeske, Y. W. A., Brown, D., Walker, R. M., Cowley, D. M., Bowling, F. G., Liaskou, D., Harris, M. A., Thomsett, M. J., et al. (2007) · Pediatric and Developmental Pathology · doi:10.2350/06-04-0083.1 · Cited by 20
Powell, P. D., Bellanné‐Chantelot, C., Flanagan, S. E., Ellard, S., Rooman, R., Hussain, K., Skae, M. S., Clayton, P., de Lonlay, P., Dunne, M. J., et al. (2011) · Diabetes · doi:10.2337/db10-1443 · Cited by 19
Self-citationKapoor, R. R., Flanagan, S. E., Ellard, S., & Hussain, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04203.x · Cited by 12
Self-citationPrenatal Diagnosis and Postnatal Management of Diffuse Congenital Hyperinsulinism: A Case Report
Peranteau, W. H., Ganguly, A. A., Steinmuller, L., THORNTON, P. S., Johnson, M. P., Howell, L. J., Stanley, C. A., & Adzick, N. S. (2006) · Fetal Diagnosis and Therapy · doi:10.1159/000095664 · Cited by 12
Permanent Neonatal Diabetes Caused by a Novel Mutation
Jain, V., Kumar, S., Flanagan, S. E., & Ellard, S. (2012) · Indian Pediatrics · doi:10.1007/s13312-012-0093-6 · Cited by 11
Self-citationCongenital hyperinsulinism caused by mutations in ABCC8 (SUR1) gene.
Thakur, S., Flanagan, S. E., Ellard, S., & Verma, I. C. (2011) · PubMed · Cited by 6
Self-citationHosy, E., Dupuis, J. P., & Vivaudou, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043307 · Cited by 5
(2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00887.x · Cited by 3
Research works printed but not linked: 1
- 2004, Molecular genetics and metabolism, 81, S45
Cited by
Sorted by citations
Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Valin, P. S., Proverbio, M. C., Diceglie, C., Gessi, A., Candia, S. D., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
Franco, E. D., Saint‐Martin, C., Brusgaard, K., Johnson, A. E. K., Aguilar‐Bryan, L., Bowman, P., Arnoux, J., Larsen, A. R., Sanyoura, M., Greeley, S. A. W., et al. (2020) · Human Mutation · doi:10.1002/humu.23995 · Cited by 181
“Mutations in these two genes together account for 36–70% of CHI cases (Kapoor et al., 2013; Snider et al., 2013).”
BackgroundSelf-citationCongenital Hyperinsulinism: Diagnosis and Treatment Update
Demirbilek, H., & Hussain, K. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2017.s007 · Cited by 173
“HH can be transient due to certain risk factors, such as birth asphyxia, intra-uterine growth retardation, maternal diabetes mellitus (5), or associated with various overgrowth syndromes like Beckwith-Wiedemann syndrome or metabolic conditions such as congenital disorders of glycosylation (6).”
BackgroundInfluentialSelf-citationCongenital hyperinsulinism: current status and future perspectives
Yorifuji, T. (2014) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2014.19.2.57 · Cited by 156
Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia
Banerjee, I., Salomon‐Estebanez, M., Shah, P., Nicholson, J., Cosgrove, K. E., & Dunne, M. J. (2018) · Diabetic Medicine · doi:10.1111/dme.13823 · Cited by 142
Metadata
- Authors
- Kapoor, R. R., Flanagan, S. E., Arya, V. B., Shield, J. P., Ellard, S., & Hussain, K.
- Affiliations
- Great Ormond Street Hospital (GB)
- University of Exeter (GB)
- Corresponding author
- Hussain, Khalid
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04
- Volume
- 168
- Issue
- 4
- Pages
- 557-564
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- PMC
- PMC3599069
- OpenAlex
- W2111189973
- Semantic Scholar
- 1a21aa2a4c44a96603182b698464b7e013b7884f
- Cited by
- 243
- References
- 81
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 25 · 2021: 23 · 2020: 21 · 2019: 20 · 2018: 13 · 2017: 12 · 2016: 12 · 2015: 27 · 2014: 22 · 2013: 6
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- European Journal of Endocrinology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Wellcome Trust (081188/A/06/Z)
- Society for Endocrinology
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- congenital hyperinsulinism, ABCC8, KCNJ11, HNF4α, GLUD1, hydroxyacyl-CoA dehydrogenase, glucokinase, MCT1, genetic diagnosis, recessive inheritance, paternal mutations, diffuse hyperinsulinism, hyperammonemia, consanguinity, genotype-phenotype correlation
- MeSH terms
- Kcnj11 Channel, Diazoxide, Female, Humans, Infant, Infant, Newborn, Male, Mutation, Receptors, Drug, Cohort Studies, ATP-Binding Cassette Transporters, Potassium Channels, Inwardly Rectifying, Congenital Hyperinsulinism, Sulfonylurea Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review